Persistent Asset Partners Ltd Reduces Position in Tenet Healthcare Corporation $THC

Persistent Asset Partners Ltd cut its holdings in Tenet Healthcare Corporation (NYSE:THC) by 48.4% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 6,456 shares of the company’s stock after selling 6,065 shares during the period. Persistent Asset Partners Ltd’s holdings in Tenet Healthcare were worth $1,311,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently bought and sold shares of the company. NewEdge Advisors LLC increased its holdings in shares of Tenet Healthcare by 6.1% in the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after purchasing an additional 166 shares during the period. Jones Financial Companies Lllp boosted its stake in shares of Tenet Healthcare by 299.1% in the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC bought a new position in shares of Tenet Healthcare during the second quarter valued at about $290,000. Chicago Partners Investment Group LLC purchased a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $273,000. Finally, Stephens Inc. AR purchased a new stake in shares of Tenet Healthcare during the second quarter worth about $306,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $227.68 on Friday. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $235.77. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The company has a 50 day moving average price of $201.26 and a 200-day moving average price of $196.69. The firm has a market capitalization of $19.80 billion, a PE ratio of 14.70, a P/E/G ratio of 1.14 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same period in the previous year, the business earned $3.44 EPS. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities research analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on THC. Cantor Fitzgerald lifted their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a research note on Wednesday, October 29th. UBS Group lifted their price objective on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Truist Financial raised their price target on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday. Guggenheim upped their price target on shares of Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a research note on Friday, February 13th. Finally, Royal Bank Of Canada lifted their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $246.71.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.